Literature DB >> 20002714

The 10 mL syringe is useful in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre.

Gavin Smith1, Malcolm J Boyle.   

Abstract

OBJECTIVE: The Valsalva manoeuvre (VM) continues to be first-line management for haemodynamically stable supraventricular tachycardia in the acute setting. 40 mmHg of intrathoracic pressure is seen as an essential component of the VM. Anecdotally, blowing into a 10 mL syringe to move the plunger is one method of pressure generation; however, to date its effectiveness has not been tested. The objective of the present study was to assess if blowing into a syringe sufficient to move the plunger could produce the required 40 mmHg of pressure.
METHODS: A two-part experimental study tested the pressure required to move the plunger, and sustain that movement for 15 s, in a Terumo syringe. Part one tested a range of syringe sizes. Part two, a repeated measures study, tested the syringe to ascertain if a pressure reduction occurred after repeated use. A sphygmomanometer was attached to the syringe via a 10 cm length of tubing with another length of tubing attached to the sphygmomanometer enabling an investigator to blow into the syringe.
RESULTS: In part one, the 10 mL syringe was the only size noted to provide the required 40 mmHg pressure to move the plunger. In part two, the mean for each of the three tests per syringe varied between 37.0 mmHg (95% CI 34.2-39.8) and 40.2 mmHg (95% CI 37.5-43.0). There was no statistically significant fall noted over three uses of the same syringe.
CONCLUSION: The present study has demonstrated that blowing into a 10 mL Terumo syringe, to move the plunger, generated 40 mmHg intrathoracic pressure, thereby meeting the recommended intrathoracic pressure for optimum VM performance.

Entities:  

Mesh:

Year:  2009        PMID: 20002714     DOI: 10.1111/j.1742-6723.2009.01228.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  6 in total

Review 1.  Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia.

Authors:  Gavin D Smith; Meagan M Fry; David Taylor; Amee Morgans; Kate Cantwell
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

2.  Randomised Controlled Trial Assessing Head Down Deep Breathing Method Versus Modified Valsalva Manoeuvre for Treatment of Supraventricular Tachycardia in the Emergency Department.

Authors:  Hoon Chin Lim; Yi-En Clara Seah; Arshad Iqbal; Vern Hsen Tan; Shieh Mei Lai
Journal:  West J Emerg Med       Date:  2021-07-20

3.  Evaluation of pre-hospital use of a valsalva assist device in the emergency treatment of supraventricular tachycardia [EVADE]: a randomised controlled feasibility trial.

Authors:  Andrew Appelboam; Jonathan Green; Paul Ewings; Sarah Black
Journal:  Pilot Feasibility Stud       Date:  2020-05-25

4.  Prehospital conversion of paroxysmal supraventricular tachycardia using the modified Valsalva maneuver: A case report.

Authors:  Padarath Gangaram; Yugan Pillay; Bernard Christopher Pillay; Guillaume Alinier
Journal:  Qatar Med J       Date:  2020-11-27

5.  Modified Valsalva manoeuvre to treat recurrent supraventricular tachycardia: description of the technique and its successful use in a patient with a previous near fatal complication of DC cardioversion.

Authors:  Andrew Appelboam; James Gagg; Adam Reuben
Journal:  BMJ Case Rep       Date:  2014-07-08

6.  Randomised Evaluation of modified Valsalva Effectiveness in Re-entrant Tachycardias (REVERT) study.

Authors:  Andrew Appelboam; Adam Reuben; Clifford Mann; Trudie Lobban; Paul Ewings; Jonathan Benger; Jane Vickery; Andrew Barton; James Gagg
Journal:  BMJ Open       Date:  2014-03-12       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.